2,16-Di(1-piperidinyl)androstane-3,17-diol(CAS: 13522-16-2)

2,16-Di(1-piperidinyl)androstane-3,17-diol (CAS: 13522-16-2) should be handled according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes appropriate hazard communication labels and safety data sheets. It is also subject to the European Union’s Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulations. Additionally, the US FDA and EPA may have specific requirements for its use and disposal in pharmaceutical and environmental contexts.

In the synthesis of similar compounds, alternatives to 2,16-Di(1-piperidinyl)androstane-3,17-diol (CAS: 13522-16-2) may include other steroidal and non-steroidal analogs. Common alternative reagents include piperidine derivatives and other steroidal intermediates. Isomers and structural analogs such as androstane-3,17-diol and 16-androstanedione may also be considered.

The market for 2,16-Di(1-piperidinyl)androstane-3,17-diol (CAS: 13522-16-2) is primarily driven by its use in pharmaceutical research, particularly in the development of novel hormone therapies. Research trends indicate an increasing interest in its biological properties and potential applications in treating hormonal imbalances and related conditions. Market dynamics reflect this growing interest, with a focus on emerging research fields and potential clinical applications.

Waste containing 2,16-Di(1-piperidinyl)androstane-3,17-diol (CAS: 13522-16-2) should be collected and disposed of in accordance with local environmental regulations. It is recommended to use professional waste disposal services for incineration or other appropriate methods to ensure environmental safety. Proper storage and handling of the waste should be carried out in a secure and isolated manner to prevent environmental contamination. Safety precautions should be followed to protect workers and the environment during disposal.